Cargando…
Rationale, Design and Methods of the Prospective Record of the Use of Dabigatran in Patients with Acute Stroke or TIA (PRODAST) Study
BACKGROUND: The optimal timing of anticoagulation following acute ischaemic stroke or TIA in patients with atrial fibrillation (AF) is a frequent challenge. Early initiation of anticoagulation can reduce the risk for recurrent ischaemic events, but may lead to an increased risk for intracerebral hae...
Autores principales: | Grosse, Gerrit M., Weimar, Christian, Kuklik, Nils, Hüsing, Anika, Stang, Andreas, Brinkmann, Marcus, Eschenfelder, Christoph C., Diener, Hans-Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948515/ https://www.ncbi.nlm.nih.gov/pubmed/35342819 http://dx.doi.org/10.1177/23969873211060219 |
Ejemplares similares
-
Early or late initiation of dabigatran versus vitamin-K-antagonists in acute ischemic stroke or TIA: The PRODAST study
por: Grosse, Gerrit M, et al.
Publicado: (2023) -
Outcome after intracranial hemorrhage under dabigatran and reversal with idarucizumab versus under vitamin-K-antagonists – the RIC-ICH study
por: Kuklik, Nils, et al.
Publicado: (2023) -
Idarucizumab as Antidote to Intracerebral Hemorrhage under Treatment with Dabigatran
por: Held, Valentin, et al.
Publicado: (2016) -
Antiplatelet therapy in secondary stroke prevention – state of the art
por: Diener, Hans-Christoph, et al.
Publicado: (2010) -
Alzheimer’s Disease—Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran
por: Grossmann, Klaus
Publicado: (2021)